Cargando…
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
INTRODUCTION: Cyclooxygenase-2 (COX-2) is frequently over-expressed in primary breast cancer. In transgenic breast cancer models, over-expression of COX-2 leads to tumour formation while COX-2 inhibition exerts anti-tumour effects in breast cancer cell lines. To further determine the effect of COX-2...
Autores principales: | Brandão, Rita D, Veeck, Jürgen, Van de Vijver, Koen K, Lindsey, Patrick, de Vries, Bart, van Elssen, Catharina HMJ, Blok, Marinus J, Keymeulen, Kristien, Ayoubi, Torik, Smeets, Hubert JM, Tjan-Heijnen, Vivianne C, Hupperets, Pierre S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672758/ https://www.ncbi.nlm.nih.gov/pubmed/23566419 http://dx.doi.org/10.1186/bcr3409 |
Ejemplares similares
-
Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010) -
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017) -
The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review
por: van Gorkom, Gwendolyn N.Y., et al.
Publicado: (2019) -
Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
por: van Gelder, Michel, et al.
Publicado: (2016) -
The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study
por: de Ruijter, Tim C., et al.
Publicado: (2019)